Alpha Tau Medical Ltd. (DRTS) Cash Flow Statement
Alpha Tau Medical Ltd. (DRTS) generated -$12.8M of operating cash flow over the twelve months to 2026-06-30, spent $3.3M on capital expenditure and had free cash flow of -$16.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DRTSAlpha Tau Medical Ltd.Follow DRTS — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 19 Nov, in 26 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -11.8 | -23.9 | -18.0 | -19.8 | -26.7 | -12.8 | |
| Capital expenditure | 2.9 | 0.9 | 6.4 | 2.2 | 6.1 | -3.3 | |
| Free cash flow | -14.7 | -24.8 | -24.4 | -22.0 | -32.8 | -16.1 | |
| Stock-based compensation | 0.8 | 6.7 | 7.9 | 9.9 | 10.6 | — |
USD millions · SEC XBRL
Alpha Tau Medical Ltd. — questions
- What is Alpha Tau Medical Ltd.'s operating cash flow?
- -$12.8M over the twelve months to 2026-06-30.
- How much does Alpha Tau Medical Ltd. spend on capital expenditure?
- $3.3M over the twelve months to 2026-06-30.
- What is Alpha Tau Medical Ltd.'s free cash flow?
- -$16.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Alpha Tau Medical Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.